US retains lead over Europe in clinical trial speed

newsbytejuly 26The United States remains the quickest country to get new medicines from clinical trial applications into patients, according to new data from the UK.

On average, it took a 155-day turnaround time in the US to approve trials and then set up a clinical study, including recruiting patients. In the UK, it look nearly 100 days longer on average.



Attracting investment for research infrastructures

New research infrastructures (RIs) are needed in Europe to maintain and propel its leadership in science and technology for decades to come. But how can new RIs attract adequate investment? How can their socio-economic and scientific impacts best be assessed?

Sponsored by Elsevier.

19 Jul 2022